{"SPADE_UN_17194": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17194", "Peptide Name": "", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "CLLFVY", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C38H56N6O8S", "Mass": 756.95, "PI": 5.52, "Net Charge": 0, "Hydrophobicity": 2.63, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells", "Pubmed ID": "23796364", "Reference": "J Am Chem Soc. 2013 Jul 17;135(28)10418-25.", "Author": "Miranda E, Nordgren IK, Male AL, Lawrence CE, Hoakwie F, Cuda F, Court W, Fox KR, Townsend PA, Packham GK, Eccles SA, Tavassoli A.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23796364"}], "Frequent Amino Acids": "LCF", "Absent Amino Acids": "ADEGHIKMNOPQRSTUW", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 3, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03536", "Similarity": 1.0, "Sequence": "ERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGMGPRPKACFFDCHYGCWCTGKLYRRKRDRKCVPKHECLL"}, {"SPADE_ID": "SPADE_N_13488", "Similarity": 1.0, "Sequence": "GICRCVCTRGFCRCICLL"}, {"SPADE_ID": "SPADE_N_13671", "Similarity": 1.0, "Sequence": "GICRCVCRRGVCRCICLL"}]}}}